The dark side of paclitaxel

  • Alekha K. Dash | AlekhaDash@creighton.edu Department of Pharmacy Sciences, School of Pharmacy and Health Professions, Creighton University, Omaha, United States.

Abstract

The bark extract of Pacific Yew (Taxus brevifolia) was first reported to have anti-tumor activity in 1963. The active constituent responsible for this activity was later identified in 1971 as paclitaxel [1]. Paclitaxel is a cytotoxic drug used in the treatment of variety of tumors including ovarian, breast, and non-small-cell lung cancers...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2011-12-05
Info
Issue
Section
Editorials
Statistics
  • Abstract views: 973

  • FULL TEXT: 148
How to Cite
Dash, A. K. (2011). The dark side of paclitaxel. Oncology Reviews, 4(2), 71-72. https://doi.org/10.4081/oncol.2010.50